Advertisement

Topics

Clinical Trials About "Vishay Intertechnology 0207 MELF Resistor Receives China 2015" RSS

03:19 EST 13th December 2018 | BioPortfolio

We list hundreds of Clinical Trials about "Vishay Intertechnology 0207 MELF Resistor Receives China 2015" on BioPortfolio. We draw our references from global clinical trials data listed on ClinicalTrials.gov and refresh our database daily.

More Information about "Vishay Intertechnology 0207 MELF Resistor Receives China 2015" on BioPortfolio

We have published hundreds of Vishay Intertechnology 0207 MELF Resistor Receives China 2015 news stories on BioPortfolio along with dozens of Vishay Intertechnology 0207 MELF Resistor Receives China 2015 Clinical Trials and PubMed Articles about Vishay Intertechnology 0207 MELF Resistor Receives China 2015 for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Vishay Intertechnology 0207 MELF Resistor Receives China 2015 Companies in our database. You can also find out about relevant Vishay Intertechnology 0207 MELF Resistor Receives China 2015 Drugs and Medications on this site too.

Showing "Vishay Intertechnology 0207 MELF Resistor Receives China 2015" Clinical Trials 1–25 of 1,600+

Relevant

China Rural Health Initiative Follow up Study

China Rural Health Initiative (CRHI), a large-scale, factorial, cluster-randomized, controlled trial was conducted in 120 villages selected from 5 Northern Provinces of rural China between 2010 and 2012. Two interventions were evaluated through CRHI. One is the standard disease management program of individuals at high risk of cardiovascular disease delivered by Primary Care Providers (village doctors). Another one is a community-based Salt Reduction program delivered by commu...


China Registry for Genetic / Metabolic Liver Diseases

CR-GMLD registry started on June 13, 2015 to collect cases of genetic/metabolic liver diseases from tertiary or secondary hospitals in mainland China. Demographics, diagnosis, laboratory test results, family history and prescriptions were recorded. Patients' whole blood and serum were collected for genetic testing and future researches. These patients will be followed-up every six to twelve months.

SYNERGY China: Assess SYNERGY Stent in China

Prospective, multicenter, single-arm study, enroll 100 patients in no more than 10 sites across China, the primary endpoint is Technical success.


Clinic Registry Study of Optic Neuromyelitis Spectrum Disease in China

In 1894, Devic first proposed the concept of neuromyelitis optica(NMO). NMO is an inflammatory demyelinating disease that selectively affects the central nervous system of the optic nerve and spinal cord.In 2004, Lennon and other persons found highly specific AQP4(aquaporin 4)antibodies in NMO patients'sera, and further differentiated between NMO and MS, confirming that NMO is an independent disease.At present, NMO has been widely recognized as an idiopathic and severe demy...

Trevo® Retriever Registry (China)

Trevo® Retriever Registry (China) is to assess real world performance of the SDA cleared Trevo Retriever intended to restore blood flow in the neurovasculature by removing thrombus in patients experiencing ischemic stroke in China.

Bacterial and Antimicrobial Susceptibility Profile and the Prevalence of Different Sites of Infection(BASPP)

Positive results of bacterial culture are analyzed comprehensively in Shengjing Hospital of China Medical University in recent 3 years(between 2015- 2017)

The Effect of Message Framing on Blood Donation-Study 1

Rh negative blood group is a rare blood group in China, as it only accounts for 0.3-0.4 percent of the Han population. Therefore, low inventory is often found in blood collection and supply agencies in many regions in China. On July 18, 2018 blood stockpile of O-negative and B-negative in Guangzhou Blood Center reached the warning line, and we took measures for emergency recruitment. O-negative and B-negative blood donors whose last donation dates were between January 1, 2015 a...

China PEACE Millions Persons Project

China PEACE Millions Persons Project is a national screening project for cardiovascular disease in China. This Project was approved by National Health and Family Planning Commission (NHFPC), China and founded by Ministry of Finance, China in 2014. The specific objectives of the project are to: 1. identify subjects at high-risk of CVD and provide counseling for medication and lifestyle improvements 2. evaluate the feasibility of such screening methods for subje...

A Study to Evaluate Persistence of Immune Responses After Post-exposure Prophylaxis of Rabipur® (Purified Chicken-embryo Cell Rabies Vaccine) in Chinese Children

The purpose of this study is to evaluate the long-term persistence of immune responses approximately 5 years or more after simulated rabies post-exposure prophylaxis provided in 2012 according to Essen (1-1-1-1-1) or Zagreb (2-1-1) intramuscular (IM) regimens in the subset of subjects who participated in the parent study (V49_24 [NCT01680016]) who were aged ≥6 and ≤17 years at the time of enrollment. This study is aimed to respond to a post-marketing commitment by the Chin...

Open Label Study (Everyone Who Participates Receives Drug) to Further Determine How Safe and Effective Oral Treatment of Seletracetam is in Patients With Refractory Epilepsy.

This is a safety and efficacy study of add on therapy with seletracetam in patients experiencing refractory epilepsy.

Study of China Heart Failure Registry to Investigate Characteristics of Patients in China

The purpose of this study is to assess clinical characteristics, treatment, and outcome of patients hospitalized with heart failure in China and compared those with other registries

Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China

In a hospital-based multi-center study in China, HPV 16 was found to be the predominant type (72.9%) in cervical cancer, followed by HPV 18(8.0%) which indicated that if the HPV prophylactic vaccine are wisely applied in China, about 80% of cervical cancer can be prevented.The reported prevalence of HPV in the female population in China was about 13.2%, with women in the study between ages 15-55. HPV prevalence peaks in young adults (ages 20-24:15.5%) and pre-menopausal women (...

HIV Assessment in Fuyang, Anhui Province, China

The purpose of this study was to examine the needs, concerns, stigmas, and social networks of HIV infected former plasma donors (FPDs) and their relatives in Fuyang, Anhui Province, China. Interviews and focus groups were used to collect data in preparation for a future, larger behavioral study for HIV infected individuals in China.

A Retrospective Study on Hospitalized Patients With Community-acquired Pneumonia in China (CAP-China)

The purpose of this study is to evaluate the disease burden of hospitalized patients with CAP and healthcare-associated pneumonia (HCAP) in real life of China .

Long-term Outcomes of Superficial Esophageal Squamous Cell Carcinoma

Tumor is the primary public health problem and the incidence of esophageal cancer showed the increasing trend in the past thirty years. According to the statistics in 2015, the new onset of esophageal cancer is about 477,900 yearly. The mainly pathologic type of esophageal cancer in China is esophageal squamous cell carcinomas, which accounts for more than 90% of patients in China. With the development of endoscopic technics, more and more patients choose to receive the endosco...

SouthErn China REgisTry for Stroke on Traditional Chinese Medicine

Stroke is the first most common cause of death in China and one of the major causes of functional disability in the adult population.The burden of stoke is significantly increased in China in recent years. In order to investigate the prognosis of stroke, with diagnostic and treatment information of traditional Chinese medicine (TCM), and assess the effectiveness and safety of TCM for stroke in southern China, the investigators will conduct this multicenter prospective registry...

Immunogenicity and Safety of Fluzone® Quadrivalent, Southern Hemisphere 2015 Formulation (Intramuscular Route)

The aim of the study was to assess the immunogenicity and safety of Fluzone Quadrivalent influenza vaccine Southern Hemisphere (SH) 2015 formulation in participants aged 18 to 60 years as well as in participants 61 years or older. The objectives were: - To evaluate the compliance, in terms of immunogenicity, of the Fluzone Quadrivalent influenza vaccine SH 2015 formulation with the requirements of the European Medicines Agency (EMA) Note for guidance (NfG) ...

Realize the Current Situation of COPD Patients in China

This is a multi-centre, prospective, observational study to realize the current situation of COPD patients in China. About 5000 COPD patients will be enrolled from 50 participating sites around China and followed up for one year. During this study, patients will undergo clinical assessments and receive medical care as determined by their treating physician.

Multicenter Epidemiologic Study of Severe Community Acquired Pneumonia in China

This study is aimed to understand the clinical characteristics, etiology and resistance phenotype of major pathogens of SCAP in China through multicenter and prospective investigation. Thus to provide epidemiological basis for improving the SCAP diagnosis and treatment protocol suitable for China.

Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults

The aim of the study is to evaluate the safety and immunogenicity of the 2015-2016 formulations of Fluzone Quadrivalent and Fluzone Intradermal Quadrivalent vaccines in adults 18 to < 65 years of age, and of the 2015-2016 formulations of Fluzone Quadrivalent and Fluzone High-Dose vaccines in adults ≥ 65 years of age. Primary Objective: - To describe the safety of the 2015-2016 formulations of Fluzone Quadrivalent and Fluzone Intradermal Quadrivalent vaccines in adults...

Pumps for Kids, Infants, and Neonates

PumpKIN is a randomized, multicenter, two-arm trial evaluating the investigational Infant Jarvik 2015 versus the EXCOR® Pediatric VAD in pediatric patients with heart failure. This study will enroll 88 subjects, 44 in receiving the Jarvik 2015 VAD and 44 receiving the EXCOR®, at up to 22 sites in the US and Canada. IVC filter subjects at up to 60 sites in the US. All treated subjects will be evaluated at procedure, 3-months, 6-months (phone), 12-months, 18-months (phone), an...

Factors Influencing Cancer Patients Participation in Clinical Trials in China.

This research studies factors affecting Chinese patient participation in cancer clinical trials and their knowledge regarding clinical trials. The investigators design this study to determining how patients makes decisions about participating in a clinical trial and know about patients' attitude toward clinical trials. The investigators aim to find ways to make cancer clinical trials in China more efficient and satisfied patients participating in clinical trials in China.

Telatinib Safety and Pharmacokinetics Study in China Patients With Advanced Solid Tumors

The purpose of this China Phase I bridging study is to to evaluate the safety, tolerability and pharmacokinetic profile of telatinib in China patients with advanced solid tumor

Hypophosphatemia as a Predictor in Surgical Resuscitation Sepsis

Retrospective study in the surgical intensive care unit of the Brest Teaching Hospital (France) during a 6-months period (January 2015 -May 2015) to study the independent association between hypophosphatemia and 28-day infection.

China Evera MRI® Study

The study is a prospective, single arm, non-blinded, multi-site study conducted in mainland China.


More From BioPortfolio on "Vishay Intertechnology 0207 MELF Resistor Receives China 2015"

Advertisement
Quick Search
Advertisement
Advertisement